Literature DB >> 6981115

Fibronectin binds to the C1q component of complement.

D H Bing, S Almeda, H Isliker, J Lahav, R O Hynes.   

Abstract

Fibronectin immobilized to plastic tubes binds soluble C1q with a Kd of 82 +/- 2.6 nM. The binding of fibronectin to C1q is relatively insensitive to pH but is sensitive to ionic conditions. C1q covalently bound to Sepharose selectively binds cellular fibronectin produced by a hamster fibroblast cell line. The globular head regions of C1q have no effect on the binding of C1q to fibronectin but the collagenous tails of C1q interfere competitively with a Ki of 59 nM. We conclude that fibronectin binds C1q via its collagen-like tail region and thus the process resembles the binding of fibronectin to gelatin. This is further emphasized by our observation that gelatin binds to fibronectin immobilized on plastic tubes with a Kd of 131 nM. Because fibronectin stimulates endocytosis in several systems and promotes the clearance of particulate material from the circulation, these results suggest the possibility that fibronectin could function in the clearance of C1q-coated material such as immune complexes or cellular debris.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981115      PMCID: PMC346605          DOI: 10.1073/pnas.79.13.4198

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Purification of opsonically active human and rat cold-insoluble globulin (plasma fibronectin).

Authors:  J Molnar; F B Gelder; M Z Lai; G E Siefring; R B Credo; L Lorand
Journal:  Biochemistry       Date:  1979-09-04       Impact factor: 3.162

2.  Formation of angiotensin III by angiotensin-converting enzyme.

Authors:  A T Chiu; J W Ryan; J M Stewart; F E Dorer
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

3.  Binding of soluble form of fibroblast surface protein, fibronectin, to collagen.

Authors:  E Engvall; E Ruoslahti
Journal:  Int J Cancer       Date:  1977-07-15       Impact factor: 7.396

Review 4.  Fibronectins--adhesive glycoproteins of cell surface and blood.

Authors:  K M Yamada; K Olden
Journal:  Nature       Date:  1978-09-21       Impact factor: 49.962

5.  C3 component of complement secreted by established cell lines.

Authors:  D R Senger; R O Hynes
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

6.  In vitro activation of complement by isolated human heart subcellular membranes.

Authors:  P C Giclas; R N Pinckard; M S Olson
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

7.  The biochemistry of complement.

Authors:  R R Porter; K B Reid
Journal:  Nature       Date:  1978-10-26       Impact factor: 49.962

8.  C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes.

Authors:  R B Sim; G J Arlaud; M G Colomb
Journal:  Biochem J       Date:  1979-06-01       Impact factor: 3.857

9.  Domain structure of fibronectin and its relation to function. Disulfides and sulfhydryl groups.

Authors:  D D Wagner; R O Hynes
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

Review 10.  High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation.

Authors:  A Vaheri; D F Mosher
Journal:  Biochim Biophys Acta       Date:  1978-09-18
View more
  36 in total

1.  Complement factors C1q, C3 and C5b-9 in the posterior sclera of guinea pigs with negative lens-defocused myopia.

Authors:  Ting-Ting Gao; Qin Long; Xue Yang
Journal:  Int J Ophthalmol       Date:  2015-08-18       Impact factor: 1.779

2.  Complement component C1q enhances invasion of human mononuclear phagocytes and fibroblasts by Trypanosoma cruzi trypomastigotes.

Authors:  M T Rimoldi; A J Tenner; D A Bobak; K A Joiner
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

3.  Novel roles of osteopontin and CXC chemokine ligand 7 in the defence against mycobacterial infection.

Authors:  V Khajoee; M Saito; H Takada; A Nomura; K Kusuhara; S-I Yoshida; Y Yoshikai; T Hara
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

4.  The C1q subunit of the first component of complement binds to laminin: a mechanism for the deposition and retention of immune complexes in basement membrane.

Authors:  J F Bohnsack; A J Tenner; G W Laurie; H K Kleinman; G R Martin; E J Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Application of quantitative trait locus mapping and transcriptomics to studies of the senescence-accelerated phenotype in rats.

Authors:  Elena E Korbolina; Nikita I Ershov; Leonid O Bryzgalov; Natalia G Kolosova
Journal:  BMC Genomics       Date:  2014-12-19       Impact factor: 3.969

6.  The immunopathology of acute experimental allergic encephalomyelitis. V. A light microscopic and ultrastructural immunohistochemical analysis of fibronectin and fibrinogen.

Authors:  R A Sobel; E E Schneeberger; R B Colvin
Journal:  Am J Pathol       Date:  1988-06       Impact factor: 4.307

7.  Antibody-independent interactions of fibronectin, C1q, and human neutrophils with Treponema pallidum.

Authors:  R E Baughn
Journal:  Infect Immun       Date:  1986-11       Impact factor: 3.441

8.  Analysis of complement deposition and processing on Chlamydia trachomatis.

Authors:  Mads Lausen; Mikkel Eggert Thomsen; Gunna Christiansen; Nichlas Karred; Allan Stensballe; Tue Bjerg Bennike; Svend Birkelund
Journal:  Med Microbiol Immunol       Date:  2020-11-18       Impact factor: 3.402

9.  Disease-specific proteins from rheumatoid arthritis patients.

Authors:  Choong Won Kim; Eun Hye Cho; Yun Jong Lee; Yoon Hee Kim; Young Sool Hah; Deok Ryong Kim
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

10.  The gene for human fibronectin glomerulopathy maps to 1q32, in the region of the regulation of complement activation gene cluster.

Authors:  M Vollmer; M Jung; F Rüschendorf; R Ruf; T Wienker; A Reis; R Krapf; F Hildebrandt
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.